Goldman Sachs Upgrades Twist Bioscience (TWST) to Buy, 'Express Genes to drive margin expansion'
Tweet Send to a Friend
(Updated - January 17, 2024 4:42 AM EST)
Goldman Sachs analyst Matthew Sykes upgraded Twist Bioscience (NASDAQ: TWST) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Matthew Sykes upgraded Twist Bioscience (NASDAQ: TWST) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
